The gloves have come off
Perhaps the most undervalued asset in diabetes devices besides a large established user base is a well-protected IP portfolio. Way back in the day Medtronic weaponized their portfolio basically forcing Smith’s Medical to take the Cozmo off the market. Recently Insulet purchased some patents from an old CGM company for both defensive and offensive purposes. And until yesterday Dexcom and Abbott have peacefully co-existed on the IP front.
Well the gloves have come off and Dexcom is taking Abbott to court and now it begins. Since we are no expert on IP we will not . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.